Assignee
MENLO THERAPEUTICS INC
US10 patents
Top patents by PatentIndex Score
US10278953B2May 7, 2019
Use of NK-1 receptor antagonist serlopitant in pruritus
MENLO THERAPEUTICS INC3 citations83
US10278952B2May 7, 2019
Use of NK-1 receptor antagonists in pruritus
MENLO THERAPEUTICS INC3 citations83
US9974769B2May 22, 2018
Use of NK-1 receptor antagonist serlopitant in pruritus
MENLO THERAPEUTICS INC5 citations83
US9968588B2May 15, 2018
Use of NK-1 receptor antagonists in pruritus
MENLO THERAPEUTICS INC5 citations83
US9737507B2Aug 22, 2017
Use of NK-1 receptor antagonist serlopitant in pruritus
MENLO THERAPEUTICS INC8 citations83
US9737508B2Aug 22, 2017
Use of NK-1 receptor antagonists in pruritus
MENLO THERAPEUTICS INC7 citations83
US9486439B2Nov 8, 2016
Use of NK-1 receptor antagonist serlopitant in pruritus
MENLO THERAPEUTICS INC7 citations83
US9474741B2Oct 25, 2016
Use of NK-1 receptor antagonists in pruritus
MENLO THERAPEUTICS INC7 citations83
US10702499B2Jul 7, 2020
Use of NK-1 receptor antagonists in pruritus
MENLO THERAPEUTICS INC1 citations72
US10617671B2Apr 14, 2020
Use of NK-1 receptor antagonist serlopitant in pruritus
MENLO THERAPEUTICS INC1 citations72